Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2020) 70 AEP1013 | DOI: 10.1530/endoabs.70.AEP1013

ECE2020 Audio ePoster Presentations Hot topics (including COVID-19) (110 abstracts)

A composite pheochromocytoma inneurofibromatosis type 1: A case report

Loukil Fatma 1 , Pinto Sara 2 , Tatulashivili Sopio 3 , Carlier Lea 4 & Bihan Helène 3


1Hopital Jean Verdier, Endocrinologie, Paris, France; 2Jean-Verdier Hospital Ap-Hp, Endocrinologie, Bondy, France; 3Avicenne Hospital (Ap-Hp), Endocrinologie, Bobigny, France; 4Jean-Verdier Hospital Ap-Hp, Endocrinologie, Bondy, France


Introduction: The composite pheochromocytoma is a rare adrenal medullatumour that combines a pheochromocytome and a neuroblastic tumour. We present the case of a composite phenochromocytoma discovered in a patient with neurofibromatosis type 1.

Case report: Patient aged 64 years referred to our department by his dermatologist for the exploration of a left adrenal mass discovered during the practice of a CT scan and then an 18F-FDG MRImade as part of an exploration of his neurofibromatosis. The patient hada high blood pressure and neurofibromatosis type 1 for which he is followed since 1995 The radiological characteristics at the 18F-FDG MRIwas in favor of a moderately hyper-metabolic formation fixing to SUV max 3.1 of the left adrenal of 18 × 12 mm and then the Adrenal-centered scanner was in favor of a left adrenal nodule that has a spontaneous density, an absolute and relative wash against the diagnosis of adenoma. In biology we noticed a slight rise in urinary and plasma metadrenaline on two successive samples. The patient was operated (left adrenalectomy) because we consideredthe mass as a pheochromocytoma. He had simple surgical suites with the need to stop antihypertensive treatment. Anatomopathological examination was in favour of a composite phenochromocytoma with a ganglioneuroma with no sign of malignancy

Discussion: The largest series of composite pheochromocytoma studied was published by Gupta et al., it included a single case of neurofibromatosis, the mean age atdiagnosis was 67years,and the average size was 5.2 cm. The majority were functionnaly activewith a moderate elevation of catecholamines. This published case is similar to our patient in clinical and biological characteristics.

Conclusion: Pheochromocytoma, as part of a neurofibromatosis, would have more specific characteristics that need to be better studied in order to refine the management of this chronic disease.

Volume 70

22nd European Congress of Endocrinology

Online
05 Sep 2020 - 09 Sep 2020

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.